BIOLIFE SOLUTIONS Aktie

0,06 EUR 685,7143%

Zu Ihrem Onlinebroker

kaufen verkaufen

BIOLIFE SOLUTIONS Aktienkurs : 08:03 ( 15 Min. verzögert)
0,0550 € Letzter Kurs	685,71% Veränderung	0,0070 € Vortag	0,0550 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,0550 - 0,0550 Tag	0,0000000 - 0,0000000 52 Wochen	0 Tag	0 Ø 52 Wochen	0,0070 0 Stücke	0,884 0 Stücke

BIOLIFE SOLUTIONS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

24.05.

“Where's the beef”, OSIR recaptures gain as sector wavers

Athersys (ATHX), BioLife Solutions (OTC BB: BLFS), BioMimetic (BMTI), Cryo-Cell (OTC BB: CCEL), Geron (GERN), Neuralstem (Amex: CUR), StemCells (STEM), Neuralstem (Amex: CUR), Opexa...
22.05.

As FB embarrasses, time for Stem Cell spotlight comeback

Minimal upward moves:Athersys (ATHX), BioLife Solutions (OTC BB: BLFS), Cryo-Cell (OTC BB: CCEL), Cytomedix (OTC BB: CMXI), ImmunoCellular (OTC BB: IMUC), International Stem Cell (OTC BB:...

16.05.

BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue

BioLife Solutions develops, manufactures and markets patented hypothermic storage and cryopreservation solutions for cells and tissues. The Company's proprietary HypoThermosol® and CryoStor® plat…
14.05.

BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue

BOTHELL, Wash., May 14, 2012 /PRNewswire via COMTEX/ -- BioLife Solutions, Inc. (OBB:BLFS) , a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for...
11.05.

RegMed Competitive and Market Intelligence 5/11/12, stocks mixed, sector ...

Flats: BioLife Solutions (OTC BB: BLFS) and ReNeuron (RENE.L). EconRecon: Consumer sentiment rose to its highest level since 2008, with the Thomson Reuters/University...